Lingling Wang

This inventor holds 1 USPTO granted patent. Top assignee: Shanxi Jinbo Bio-Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lingling Wang. Retrieved from https://idiyas.com/inventor/lingling-wang-jhws9m5a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lingling Wang: Innovator in Bio-Pharmaceuticals

Introduction

Lingling Wang is a prominent inventor in the field of bio-pharmaceuticals. She has made significant contributions to the industry through her innovative research and development efforts. Her work focuses on collagen and its various applications, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Lingling Wang holds a patent for "Collagen and Use Thereof." This patent highlights her innovative approach to utilizing collagen in various therapeutic applications. With 1 patent to her name, she continues to push the boundaries of what is possible in her field.

Career Highlights

Wang is currently employed at Shanxi Jinbo Bio-Pharmaceutical Co., Ltd., where she plays a vital role in the company's research initiatives. Her work has been instrumental in developing new bio-pharmaceutical products that leverage the benefits of collagen.

Collaborations

Throughout her career, Lingling has collaborated with notable colleagues, including Wenfei Yang and Xiaobin Lan. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.

Conclusion

Lingling Wang is a trailblazer in the bio-pharmaceutical industry, with her patent and work at Shanxi Jinbo Bio-Pharmaceutical Co., Ltd. reflecting her commitment to innovation. Her contributions are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…